Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.419ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.151ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.575.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.620ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.107ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.10 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.41 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.166ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used